1. Home
  2. FTLF vs CGTX Comparison

FTLF vs CGTX Comparison

Compare FTLF & CGTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo FitLife Brands Inc.

FTLF

FitLife Brands Inc.

N/A

Current Price

$8.08

Market Cap

73.6M

Sector

Health Care

ML Signal

N/A

CGTX

Cognition Therapeutics Inc.

N/A

Current Price

$0.71

Market Cap

79.6M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
FTLF
CGTX
Founded
2005
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
73.6M
79.6M
IPO Year
2006
2021

Fundamental Metrics

Financial Performance
Metric
FTLF
CGTX
Price
$8.08
$0.71
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
3
Target Price
★ $17.50
$3.33
AVG Volume (30 Days)
12.7K
★ 467.9K
Earning Date
11-12-2026
11-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 62.79
EPS
★ 0.37
N/A
Revenue
★ $21,744,000.00
N/A
Revenue This Year
$30.00
N/A
Revenue Next Year
$6.35
N/A
P/E Ratio
$21.32
★ N/A
Revenue Growth
★ 11.52
N/A
52 Week Low
$7.66
$0.55
52 Week High
$19.95
$1.83

Technical Indicators

Market Signals
Indicator
FTLF
CGTX
Relative Strength Index (RSI) 42.23 35.25
Support Level $8.05 $0.55
Resistance Level $9.76 $1.18
Average True Range (ATR) 0.33 0.05
MACD -0.00 0.00
Stochastic Oscillator 43.59 37.33

Price Performance

Historical Comparison
FTLF
CGTX

About FTLF FitLife Brands Inc.

FitLife Brands Inc is a provider of proprietary nutritional supplements for health-conscious consumers. The company markets and sells its products under NDS, PMD, Siren labs, Core active, Metis nutrition, Dr. Tobias, MusclePharm, Irwin Naturals, Applied Nutrition, Isatori, and Nature's Secret brand names. Its product portfolio consists of sports nutrition, energy, sports drink products, meal replacement products, and weight loss products. The firm derives its revenue from product sales. Its product categories include Natural & Organic Foods, Functional Foods, Natural & Organic Personal Care and Household Products, and Supplements.

About CGTX Cognition Therapeutics Inc.

Cognition Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of small-molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system (CNS) and retina. It aims to develop disease-modifying therapies for patients with these disorders. Its product candidate, zervimesine (CT1812), is an orally delivered small molecule designed to protect neuronal synapses by preventing the binding of oligomers of pathogenic proteins, including beta-amyloid and alpha-synuclein. These protein oligomers have been linked to the progression of degenerative diseases such as Alzheimer's disease (AD) and dementia with Lewy bodies (DLB).

Share on Social Networks: